Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024 Life Science Investing
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY Market News
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants Life Science Investing
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants Life Science Investing
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy 27th Annual Meeting Life Science Investing
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys
